REPORTS

Let’s Pullulate and Expand Your Business

Liquid Biopsy Market - Global Professional Analysis and Forecast to 2026

Nov 07, 2019  |  219 PAGES  |  REPORT CODE: CMM230445
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Liquid Biopsy market was valued at 1157 Million US$ in 2018 and is projected to reach 2546 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.36% during the forecast period.

This report presents the market size and development trends by detailing the Liquid Biopsy market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Liquid Biopsy market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Liquid Biopsy industry and will help you to build a panoramic view of the industrial development.

Liquid Biopsy Market, By Type:

  • Blood

  • Urine

  • Other

Liquid Biopsy Market, By Application:

  • Breast Cancer

  • Colorectal Cancer

  • Liver Cancer

  • Lung Cancer

  • Prostate Cancer

  • Other Cancers

Some of the leading players are as follows:

  • Exosome Diagnostics

  • Foundation Medicine, Inc.

  • Personal Genome Diagnostic

  • Agena Bioscience

  • RainDance Technologies

  • Circulogene Theranostics

  • Inivata

  • Qiagen

  • SAGA Diagnostics AB

  • Cynvenio

  • Trovagene

  • Admeria Health Personal Genome Diagnostics

  • Biocept

  • Guardant Health

  • NeoGenomics Laboratories

  • Adaptive

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Liquid Biopsy Market: Technology Type Analysis

  • 4.1 Liquid Biopsy Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Liquid Biopsy Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Blood

    • 4.3.2 Urine

    • 4.3.3 Other

5 Liquid Biopsy Market: Product Analysis

  • 5.1 Liquid Biopsy Product Market Share Analysis, 2018 & 2026

  • 5.2 Liquid Biopsy Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Liquid Biopsy Market: Application Analysis

  • 6.1 Liquid Biopsy Application Market Share Analysis, 2018 & 2026

  • 6.2 Liquid Biopsy Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Breast Cancer

    • 6.3.2 Colorectal Cancer

    • 6.3.3 Liver Cancer

    • 6.3.4 Lung Cancer

    • 6.3.5 Prostate Cancer

    • 6.3.6 Other Cancers

7 Liquid Biopsy Market: Regional Analysis

  • 7.1 Liquid Biopsy Regional Market Share Analysis, 2018 & 2026

  • 7.2 Liquid Biopsy Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Exosome Diagnostics

    • 9.1.1 Exosome Diagnostics Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Foundation Medicine, Inc.

    • 9.2.1 Foundation Medicine, Inc. Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Personal Genome Diagnostic

    • 9.3.1 Personal Genome Diagnostic Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Agena Bioscience

    • 9.4.1 Agena Bioscience Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 RainDance Technologies

    • 9.5.1 RainDance Technologies Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Circulogene Theranostics

    • 9.6.1 Circulogene Theranostics Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Inivata

    • 9.7.1 Inivata Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Qiagen

    • 9.8.1 Qiagen Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 SAGA Diagnostics AB

    • 9.9.1 SAGA Diagnostics AB Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Cynvenio

    • 9.10.1 Cynvenio Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Trovagene

    • 9.11.1 Trovagene Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Admeria Health Personal Genome Diagnostics

    • 9.12.1 Admeria Health Personal Genome Diagnostics Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Biocept

    • 9.13.1 Biocept Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Guardant Health

    • 9.14.1 Guardant Health Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 NeoGenomics Laboratories

    • 9.15.1 NeoGenomics Laboratories Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Adaptive

    • 9.16.1 Adaptive Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

 

The List of Tables and Figures (Totals 66 Figures and 138 Tables)

  • Figure Blood Liquid Biopsy market, 2015 - 2026 (USD Million)

  • Figure Urine Liquid Biopsy market, 2015 - 2026 (USD Million)

  • Figure Other Liquid Biopsy market, 2015 - 2026 (USD Million)

  • Figure Breast Cancer market, 2015 - 2026 (USD Million)

  • Figure Colorectal Cancer market, 2015 - 2026 (USD Million)

  • Figure Liver Cancer market, 2015 - 2026 (USD Million)

  • Figure Lung Cancer market, 2015 - 2026 (USD Million)

  • Figure Prostate Cancer market, 2015 - 2026 (USD Million)

  • Figure Other Cancers market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Liquid Biopsy market, by country, 2015 - 2026 (USD Million)

  • Table North America Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table North America Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table North America Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Canada Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Canada Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Europe Liquid Biopsy market, by country, 2015 - 2026 (USD Million)

  • Table Europe Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Europe Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Europe Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Germany Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Germany Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table France Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table France Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Italy Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Italy Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Spain Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Spain Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Liquid Biopsy market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table China Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table China Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Japan Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Japan Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table India Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table India Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Liquid Biopsy market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table MEA Liquid Biopsy market, by country, 2015 - 2026 (USD Million)

  • Table MEA Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table MEA Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table MEA Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Exosome Diagnostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Foundation Medicine, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Personal Genome Diagnostic Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Agena Bioscience Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table RainDance Technologies Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Circulogene Theranostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Inivata Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Qiagen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table SAGA Diagnostics AB Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cynvenio Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Trovagene Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Admeria Health Personal Genome Diagnostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biocept Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Guardant Health Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table NeoGenomics Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Adaptive Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top